drugset / Trial / NCT00200421

A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension

NCT00200421

Phase 2 Completed 110 enrolled Mylan Bertek Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effects on exercise capacity of nebivolol compared to atenolol in hypertensive patients.

Timeline

Start
2002-05
Primary completion
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atenolol Other / unclassified
Subject Nebivolol Other / unclassified

Indications